scholarly article | Q13442814 |
P356 | DOI | 10.1038/SJ.MP.4001797 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/sj.mp.4001797 |
P698 | PubMed publication ID | 16432527 |
P5875 | ResearchGate publication ID | 7340023 |
P2093 | author name string | Sadée W | |
Papp A | |||
Saffen D | |||
Lim JE | |||
Pinsonneault J | |||
P2860 | cites work | The Psychology and Neurobiology of Suicidal Behavior | Q22255603 |
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization | Q24308751 | ||
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors | Q24531235 | ||
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene | Q27860482 | ||
The International HapMap Project | Q27860695 | ||
Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism | Q28202857 | ||
Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions | Q28274655 | ||
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region | Q28297391 | ||
Serotonin transporter genetic variation and the response of the human amygdala | Q29617804 | ||
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression | Q29618835 | ||
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. | Q30960363 | ||
Research and treatment approaches to depression | Q33945106 | ||
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders | Q34146169 | ||
Abundant raw material for cis-regulatory evolution in humans | Q34157325 | ||
Serotonin and sleep | Q34170947 | ||
Serotonin and drug reward: focus on 5-HT2C receptors | Q34277384 | ||
A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety | Q34299070 | ||
Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis. | Q44651882 | ||
Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population | Q44715723 | ||
Investigation of serotonin-related genes in antidepressant response | Q44820568 | ||
Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis | Q44879403 | ||
Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression | Q44906816 | ||
Meta-analysis of serotonin transporter polymorphisms and affective disorders | Q45022952 | ||
Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders | Q45172625 | ||
Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence | Q45213940 | ||
Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style | Q46543887 | ||
Improved PCR amplification of multiple specific alleles (PAMSA) using internally mismatched primers. | Q48062483 | ||
Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter gene | Q48251330 | ||
Cis-acting variation in the expression of a high proportion of genes in human brain | Q48319040 | ||
Early experience and serotonin transporter gene variation interact to influence primate CNS function. | Q50093769 | ||
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. | Q51408749 | ||
Allelic Variation of Human Serotonin Transporter Gene Expression | Q55934627 | ||
Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene | Q56688543 | ||
Allelic Variation in Human Gene Expression | Q57293497 | ||
Organization of the human serotonin transporter gene | Q59619269 | ||
Effects of Serotonin Transporter Promoter Genotype on Platelet Serotonin Transporter Functionality in Depressed Children and Adolescents | Q62678983 | ||
Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder | Q63869212 | ||
How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? | Q77072730 | ||
Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits | Q34316352 | ||
Alcoholism: genes and mechanisms | Q34374370 | ||
A susceptibility gene for affective disorders and the response of the human amygdala | Q34392171 | ||
Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia | Q34424389 | ||
Genetic perspectives on the serotonin transporter | Q34467017 | ||
Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake | Q34558819 | ||
Serotonin transporter: gene, genetic disorders, and pharmacogenetics | Q34649511 | ||
Serotonin brain circuits involved in major depression and suicide | Q34764127 | ||
Treatment of mood disorders | Q34982300 | ||
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior | Q35182445 | ||
New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. | Q35195703 | ||
Anxiety-related traits in mice with modified genes of the serotonergic pathway. | Q35586658 | ||
Allelic variations in gene expression | Q35611266 | ||
The human raphe nuclei and the serotonergic system. | Q35631866 | ||
Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome | Q35805941 | ||
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders | Q35810041 | ||
Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter | Q35834300 | ||
Cis-acting regulatory variation in the human genome | Q35925110 | ||
Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis | Q35984302 | ||
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments | Q36056325 | ||
Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics | Q36076320 | ||
Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. | Q36095772 | ||
Neurobiology of anorexia nervosa: clinical implications of alterations of the function of serotonin and other neuronal systems | Q36106396 | ||
The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments | Q36153942 | ||
Pharmacogenetics of the serotonin transporter | Q36160425 | ||
A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo | Q36785035 | ||
Alternative splicing of the human serotonin transporter gene | Q36885498 | ||
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. | Q40392922 | ||
A survey of genetic and epigenetic variation affecting human gene expression | Q40621976 | ||
From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters | Q40713073 | ||
Alternative non-coding exons support serotonin transporter mRNA expression in the brain and gut. | Q40717511 | ||
The spectrum of behaviors influenced by serotonin | Q40847700 | ||
Expression of serotonin transporter mRNA in human brainstem raphe nuclei | Q40922585 | ||
Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells | Q40955068 | ||
Serotonergic basis of antipsychotic drug effects in schizophrenia. | Q42537934 | ||
A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain | Q42928107 | ||
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism | Q43678211 | ||
The silencer activity of the novel human serotonin transporter linked polymorphic regions | Q44050681 | ||
Serotonin transporter availability correlates with alcohol intake in non-human primates | Q44334408 | ||
No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. | Q44398449 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | serotonin | Q167934 |
P304 | page(s) | 649-662 | |
P577 | publication date | 2006-01-24 | |
P1433 | published in | Molecular Psychiatry | Q6895973 |
P1476 | title | Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. | |
P478 | volume | 11 |
Q35130933 | Affective neural responses modulated by serotonin transporter genotype in clinical anxiety and depression |
Q33695379 | Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients |
Q42324839 | Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion |
Q37033708 | Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues |
Q37324910 | Association study of the estrogen receptor gene ESR1 with postpartum depression--a pilot study |
Q30410433 | Association, interaction, and replication analysis of genes encoding serotonin transporter and 5-HT3 receptor subunits A and B in alcohol dependence |
Q33747022 | Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR. |
Q30437148 | Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity |
Q33767378 | Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF. |
Q35844326 | Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells. |
Q81826658 | Drug therapy and personalized health care: pharmacogenomics in perspective |
Q46991332 | Enhanced serotonin transporter function during depression in seasonal affective disorder |
Q37231435 | Genes within the serotonergic system are differentially expressed in human brain |
Q37201376 | Genotyping serotonin transporter polymorphisms 5-HTTLPR and rs25531 in European- and African-American subjects from the National Institute of Mental Health's Collaborative Center for Genomic Studies |
Q56273531 | Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples |
Q24683135 | Imaging the serotonin transporter during major depressive disorder and antidepressant treatment |
Q89176656 | Influence of Serotonin Transporter SLC6A4 Genotype on the Effect of Psychosocial Stress on Cognitive Performance: An Exploratory Pilot Study |
Q33840144 | Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations |
Q39033887 | Looking Beyond the 5-HTTLPR Polymorphism: Genetic and Epigenetic Layers of Regulation Affecting the Serotonin Transporter Gene Expression |
Q36801188 | Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression |
Q35536026 | Modulation of human serotonin transporter expression by 5-HTTLPR in colon cells |
Q36981261 | Molecular genetics of monoamine transporters: relevance to brain disorders |
Q36786517 | Molecular studies of major depressive disorder: the epigenetic perspective |
Q30395001 | Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. |
Q34052418 | Next-generation DNA sequencing-based assay for measuring allelic expression imbalance (AEI) of candidate neuropsychiatric disorder genes in human brain |
Q37294726 | Novel promoter and alternate transcription start site of the human serotonin reuptake transporter in intestinal mucosa |
Q48920366 | Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour. |
Q36224018 | Parent-of-origin effects of the serotonin transporter gene associated with autism |
Q35120999 | Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect |
Q35654120 | Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy |
Q37427023 | Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues |
Q38606623 | Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants |
Q36616334 | Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). |
Q35851031 | Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder |
Q46598276 | Serotonin transporter gene variation in sudden infant death syndrome |
Q39613930 | Serotonin transporter-linked polymorphic region (5-HTTLPR) genotype is associated with cortisol responsivity to naloxone challenge. |
Q51848064 | Skewed allele-specific expression of the NF1 gene in normal subjects: a possible mechanism for phenotypic variability in neurofibromatosis type 1. |
Q50345695 | The genetic architecture of autism spectrum disorders (ASDs) and the potential importance of common regulatory genetic variants. |
Q34663662 | The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis |
Q37295518 | The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice |
Q33665523 | The serotonin transporter promoter polymorphism is associated with cortisol response to psychosocial stress |
Q95825852 | Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons |
Q28681164 | Whole transcriptome RNA-Seq allelic expression in human brain |
Search more.